Why is pregnancy sickness drug not easily accessible to all?
Summary
A drug called Xonvea helps treat severe pregnancy sickness known as Hyperemesis Gravidarum (HG). While it is approved and works well for many women, some have trouble getting it through the NHS because doctors tend to prescribe cheaper medicines first, and approval can be complicated.Key Facts
- Hyperemesis Gravidarum (HG) is a severe form of pregnancy sickness that makes women feel very sick and unable to eat.
- Xonvea is a drug approved by the UK’s Medicines Health Regulatory Authority (MHRA) specifically for treating HG.
- Some women find Xonvea more effective than other common treatments for pregnancy sickness.
- Access to Xonvea is not always easy; some women must fight to get it prescribed or pay for private appointments.
- General practitioners (GPs) often prescribe cheaper anti-sickness drugs first due to cost differences.
- Approval for prescribing Xonvea sometimes requires a consultant’s permission, causing delays.
- The Pregnancy Sickness Support charity calls access to Xonvea a "postcode lottery," meaning it depends on where a woman lives.
- Specialists recommend Xonvea but acknowledge cost and access issues affect its availability to patients.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.